Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure

Abstract

IMPORTANCE The presumed proarrhythmic action of caffeine is controversial. Few studies have assessed the effect of high doses of caffeine in patients with heart failure due to left ventricular systolic dysfunction at high risk for ventricular arrhythmias. OBJECTIVE To compare the effect of high-dose caffeine or placebo on the frequency of supraventricular and ventricular arrhythmias, both at rest and during a symptom-limited exercise test. DESIGN, SETTING, AND PARTICIPANTS Double-blinded randomized clinical trial with a crossover design conducted at the heart failure and cardiac transplant clinic of a tertiary-care university hospital. The trial included patients with chronic heart failure with moderate-to-severe systolic dysfunction (left ventricular ejection fraction <45%) and New York Heart Association functional class I to III between March 5, 2013, and October 2, 2015. INTERVENTIONS Caffeine (100 mg) or lactose capsules, in addition to 5 doses of 100 mL decaffeinated coffee at 1-hour intervals, for a total of 500 mg of caffeine or placebo during a 5-hour protocol. After a 1-week washout period, the protocol was repeated. MAIN OUTCOMES AND MEASURES Number and percentage of ventricular and supraventricular premature beats assessed by continuous electrocardiographic monitoring. RESULTS We enrolled 51 patients (37 [74%] male; mean [SD] age, 60.6 [10.9] years) with predominantly moderate-to-severe left ventricular systolic dysfunction (mean [SD] left ventricular ejection fraction, 29% [7%]); 31 [61%] had an implantable cardioverterdefibrillator device. No significant differences between the caffeine and placebo groups were observed in the number of ventricular (185 vs 239 beats, respectively; P = .47) and supraventricular premature beats (6 vs 6 beats, respectively; P = .44), as well as in couplets, bigeminal cycles, or nonsustained tachycardia during continuous electrocardiographic monitoring. Exercise test-derived variables, such as ventricular and supraventricular premature beats, duration of exercise, estimated peak oxygen consumption, and heart rate, were not influenced by caffeine ingestion. We observed no increases in ventricular premature beats (91 vs 223 vs 207 beats, respectively) in patients with higher levels of plasma caffeine concentration compared with lower plasma levels (P = .91) or with the placebo group (P = .74). CONCLUSIONS AND RELEVANCE Acute ingestion of high doses of caffeine did not induce arrhythmias in patients with systolic heart failure and at high risk for ventricular arrhythmias. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT02045992

Coffee for Cardioprotection and Longevity

“…25 Importantly, caffeine intake at doses up to 500 mg/day (equivalent to 4 or 5 cups of coffee) does not change the frequency, inducibility, or severity of ventricular arrhythmias, as shown in multiple randomized placebo-controlled trials. 26,27 Furthermore, several large prospective epidemiological studies report that consumption of coffee with or without caffeine is not associated with a heightened risk of atrial fibrillation. 28,29 Another recent cohort study followed 19,896 middle-aged university graduates…”

Inverted Takotsubo Cardiomyopathy Associated With the Consumption of a Weight Management Supplement

“…7 Amphetamine and amphetaminelike stimulants have been reported to be associated with hypertension, tachycardia, and acute coronary syndrome, and its chronic exposure may cause dilated cardiomyopathy. 8 One previous publication documented a 24-year-old man who developed ITC shortly after ingesting an energy drink Novel Teaching Points 1. ITC is an uncommon type of takotsubo cardiomyopathy, which should be well recognized by clinicians and should be on the differential list for patients with chest discomfort, ST-segment change, and left ventricular basal wall motion abnormality.…”

Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity’s Metabolic Consequences

“…In another study 68.3 mg/kg dose of coffee was administrated to 40 male rats with metabolic syndrome, cardiovascular and hepatic structure for 8–9 weeks and concluded increased cardiovascular diseases [14]. In a randomized control blinded trial, the consumption of 500 mg dose of caffeine in capsules or powder form to 137 patients with arrhythmic episodes for 2 months and resulted no arrhythmic episodes [29]. However, other studies have recently underlined the possible negative effects of the increased consumption, such as cardiac arrhythmia, etc.…”